Mount Sinai Researchers Develop First Targeted Therapy for Rare T-Cell Lymphoma Following CAR T Treatment
In a landmark development at the forefront of hematologic oncology, researchers from The Tisch Cancer Institute at the Icahn School ...
In a landmark development at the forefront of hematologic oncology, researchers from The Tisch Cancer Institute at the Icahn School ...
In a groundbreaking advancement poised to reshape the landscape of hematologic oncology, researchers at Foresight Diagnostics have unveiled the analytical ...
Barcelona, April 29, 2025 – In a pioneering leap forward in hematologic oncology, researchers at the Sant Pau Research Institute ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine